ARCHIVES

In Brief: House Committee Approves Funding Boost For NIH; Michigan Centers Receive $15M Gift

This article is from The Cancer Letter archive.

Vol. 21 No. 30 | July 28, 1995

Download PDF Visit The Full Archive

Related Articles

FDA Approval of Abraxane Sets Stage for Competition Between Taxane Drugs. Abraxane a Nanotechnology Drug? Sponsor Says Yes, FDA Says.

January 14, 2005

Long-Term Effect Of One Phase III Trial: Benefit For Thousands Of Patients

November 27, 2009

WETA Relents Will Air Documentary

April 10, 1987

An Earmark For Pancreatic Cancer

August 3, 2012

Program Announcement For Clinical Research

February 29, 1980

In Brief: First Peer-Reviewed Comprehensive Centers Named; Sawaya To Lead Anderson Neurosurgery

October 5, 1990